Lack of CCAAT Enhancer Binding Protein Beta (C/EBPβ) in uterine epithelial cells impairs estrogen-induced DNA replication, induces DNA damage response pathways, and promotes apoptosis

Molecular and Cellular Biology

Volumn 30, Issue 7, 2010, Pages 1607-1619

  Ramathal, Cyril ^a,b   Bagchi, Indrani C ^b   Bagchi, Milan K ^a,b  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; ATR PROTEIN; CCAAT ENHANCER BINDING PROTEIN BETA; CHECKPOINT KINASE 1; CYCLIN E; ESTROGEN; HISTONE H2AX; PROTEIN P21; PROTEIN P27; PROTEIN P53; TRANSCRIPTION FACTOR E2F3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL GROWTH; CELL STIMULATION; CELL SURVIVAL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DNA DAMAGE; DNA REPLICATION; ENDOMETRIUM CELL; FEMALE; GENE EXPRESSION; MOUSE; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; CALNEXIN; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CELL CYCLE; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DNA DAMAGE; DNA REPLICATION; EPITHELIAL CELLS; ESTRADIOL; FEMALE; GENE EXPRESSION PROFILING; MALE; MICE; MICE, KNOCKOUT; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROMOTER REGIONS, GENETIC; TUMOR SUPPRESSOR PROTEIN P53; UTERUS;

MUS;

EID: 77949379438     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.00872-09     Document Type: Article

References (58)

1. Bartek, J., and J. Lukas. 2001. Pathways governing G1/S transition and their response to DNA damage. FEBS Lett. 490:117-122.
2. Bi, X., L. R. Barkley, D. M. Slater, S. Tateishi, M. Yamaizumi, H. Ohmori, and C. Vaziri. 2006. Rad18 regulates DNA polymerase kappa and is required for recovery from S-phase checkpoint-mediated arrest. Mol. Cell. Biol. 26: 3527-3540.
3. Bunz, F., A. Dutriaux, C. Lengauer, T. Waldman, S. Zhou, J. P. Brown, J. M. Sedivy, K. W. Kinzler, and B. Vogelstein. 1998. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282: 1497-1501.
4. Cheng, M., P. Olivier, J. A. Diehl, M. Fero, M. F. Roussel, J. M. Roberts, and C. J. Sherr. 1999. The p21Cip1 and p27Kip1 CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J. 18: 1571-1583.
5. Cullingford, T. E., and J. W. Pollard. 1994. Growth factors as mediators of sex-steroid hormone action in the uterus during the pre-implantation period, p. 13-30. In S. A. Khan and G. M. Stancel (ed.), Protooncogenes and growth factors in steroid hormone-induced growth differentiation. CRC Press Inc., Boca Raton, FL.
6. Ekholm-Reed, S., J. Mendez, D. Tedesco, A. Zetterberg, B. Stillman, and S. I. Reed. 2004. Deregulation of cyclin E in human cells interferes with prereplication complex assembly. J. Cell Biol. 165: 789-800.
7. Endl, I. K. E., M. Baack, R. Knippers, J. Gerdes, and T. Scholzen. 2001. The expression of Ki-67, MCM3, and p27 defines distinct subsets of proliferating, resting, and differentiated cells. J. Pathol. 195: 457-462.
8. Fernandez-Capetillo, O., H. T. Chen, A. Celeste, I. Ward, P. J. Romanienko, J. C. Morales, K. Naka, Z. Xia, R. D. Camerini-Otero, N. Motoyama, P. B. Carpenter, W. M. Bonner, J. Chen, and A. Nussenzweig. 2002. DNA damage-induced G2-M checkpoint activation by histone H2AX and 53BP1. Nat. Cell Biol. 4: 993-997.
9. Ghahary, A., and L. J. Murphy. 1989. Uterine insulin-like growth factor-I receptors: regulation by estrogen and variation throughout the estrous cycle. Endocrinology 125: 597-604.
10. Gorgoulis, V. G., L.-V. F. Vassiliou, P. Karakaidos, P. Zacharatos, A. Kotsinas, T. Liloglou, M. Venere, R. A. DiTullio, N. G. Kastrinakis, B. Levy, D. Kletsas, A. Yoneta, M. Herlyn, C. Kittas, and T. D. Halazonetis. 2005. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 434: 907-913.
11. Greenbaum, L. E., W. Li, D. E. Cressman, Y. Peng, G. Ciliberto, V. Poli, and R. Taub. 1998. CCAAT enhancer-binding protein beta is required for normal hepatocyte proliferation in mice after partial hepatectomy. Clin. Invest. 102: 996-1007.
12. Grimm, S. L., A. Contreras, M.-H. Barcellos-Hoff, and J. M. Rosen. 2005. Cell cycle defects contribute to a block in hormone-induced mammary gland proliferation in CCAAT/enhancer-binding protein (C/EBP beta)-null mice. J. Biol. Chem. 280: 36301-36309.
13. Gu, Y., J. Rosenblatt, and D. O. Morgan. 1992. Cell cycle regulation of CDK2 activity by phosphorylation of Thr160 and Tyr15. EMBO J. 11: 3995-4005.
14. Harper, J. V., and G. Brooks. 2005. The mammalian cell cycle: an overview. In H. T. Brooks (ed.), Cell cycle control: mechanisms and protocols. Humana Press Inc., Totowa, NJ.
15. Heinemeyer, T., E. Wingender, I. Reuter, H. Hermjakob, A. E. Kel, O. V. Kel, E. V. Ignatieva, E. A. Ananko, O. A. Podkolodnaya, F. A. Kolpakov, N. L. Podkolodny, and N. A. Kolchanov. 1998. Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL. Nucleic Acids Res. 26: 362-367.
16. Hendzel, M. J., Y. Wei, M. A. Mancini, A. Van Hooser, T. Ranalli, B. R. Brinkley, D. P. Bazett-Jones, and D. C. Allis. 1997. Mitosis-specific phosphorylation of histone H3 initiates primarily within pericentromeric heterochromatin during G2 and spreads in an ordered fashion coincident with mitotic chromosome condensation. Chromosoma 106: 348-360.
17. Hewitt, S. C., B. J. Deroo, K. Hansen, J. Collins, S. Grissom, C. A. Afshari, and K. S. Korach. 2003. Estrogen receptor-dependent genomic responses in the uterus mirror the biphasic physiological response to estrogen. Mol. Endocrinol. 17: 2070-2083.
18. Hewitt, S. C., J. C. Harrell, and K. S. Korach. 2005. Lessons in estrogen biology from knockout and transgenic animals. Annu. Rev. Physiol. 67: 285-308.
19. Humbert, P. O., R. Verona, J. M. Trimarchi, C. Rogers, S. Dandapani, and J. A. Lees. 2000. E2F3 is critical for normal cellular proliferation. Genes Dev. 14: 690-703.
20. Kim, J., M. Sato, Q. Li, J. P. Lydon, F. J. DeMayo, I. C. Bagchi, and M. K. Bagchi. 2008. Peroxisome proliferator-activated receptor gamma is a target of progesterone regulation in the preovulatory follicles and controls ovulation in mice. Mol. Cell. Biol. 28: 1770-1782.
21. Kong, L.-J., J. T. Chang, A. H. Bild, and J. R. Nevins. 2006. Compensation and specificity of function within the E2F family. Oncogene 26: 321-327.
22. Leone, G., J. DeGregori, Z. Yan, L. Jakoi, S. Ishida, R. S. Williams, and J. R. Nevins. 1998. E2F3 activity is regulated during the cell cycle and is required for the induction of S phase. Genes Dev. 12: 2120-2130.
23. Lubahn, D., J. Moyer, T. Golding, J. Couse, K. Korach, and O. Smithies. 1993. Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc. Natl. Acad. Sci. U. S. A. 90: 11162-11166.
24. Luetteke, N., T. Qiu, S. Fenton, K. Troyer, R. Riedel, A. Chang, and D. Lee. 1999. Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in mouse mammary gland development. Development 126: 2739-2750.
25. Luetteke, N. C., T. H. Qiu, R. L. Peiffer, P. Oliver, O. Smithies, and D. C. Lee. 1993. TGF alpha deficiency results in hair follicle and eye abnormalities in targeted and waved-1 mice. Cell 73: 263-278.
26. Lydon, J. P., F. J. DeMayo, C. R. Funk, S. K. Mani, A. R. Hughes, C. A. Montgomery, Jr., G. Shyamala, O. M. Conneely, and B. W. O'Malley. 1995. Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes Dev. 9: 2266-2278.
27. Maddika, S., S. R. Ande, S. Panigrahi, T. Paranjothy, K. Weglarczyk, A. Zuse, M. Eshraghi, K. D. Manda, E. Wiechec, and M. Los. 2007. Cell survival, cell death and cell cycle pathways are interconnected: implications for cancer therapy. Drug Resist. Updat. 10: 13-29.
28. Mantena, S. R., A. Kannan, Y.-P. Cheon, Q. Li, P. F. Johnson, I. C. Bagchi, and M. K. Bagchi. 2006. C/EBPbeta is a critical mediator of steroid hormone-regulated cell proliferation and differentiation in the uterine epithelium and stroma. Proc. Natl. Acad. Sci. U. S. A. 103: 1870-1875.
29. Martin, L., J. W. Pollard, and B. Fagg. 1976. Oestriol, oestradiol-17β and the proliferation and death of uterine cells. Endocrinology 69: 103-115.
30. McKnight, S. L. 2001. McBindall - a better name for CCAAT/enhancer binding proteins? Cell. 107: 259-261.
31. Monroe, D. G., R. R. Berger, and M. M. Sanders. 2002. Tissue-protective effects of estrogen involve regulation of caspase gene expression. Mol. Endocrinol. 16: 1322-1331.
32. Morgan, D. O. 1995. Principles of CDK regulation. Nature 374: 131-134.
33. Mukku, V., and G. Stancel. 1985. Regulation of epidermal growth factor receptor by estrogen. J. Biol. Chem. 260: 9820-9824.
34. Muller, H., A. P. Bracken, R. Vernell, M. C. Moroni, F. Christians, E. Grassilli, E. Prosperini, E. Vigo, J. D. Oliner, and K. Helin. 2001. E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis. Genes Dev. 15: 267-285.
35. Muller, H., and K. Helin. 2000. The E2F transcription factors: key regulators of cell proliferation. Biochim. Biophys. Acta 1470: M1-M12.
36. Nakajima, S., L. Lan, S. Kanno, N. Usami, K. Kobayashi, M. Mori, T. Shiomi, and A. Yasui. 2006. Replication-dependent and -independent responses of RAD18 to DNA damage in human cells. J. Biol. Chem. 281: 34687-34695.
37. Nelson, K. G., T. Takahashi, N. L. Bossert, D. K. Walmer, and J. A. McLachlan. 1991. Epidermal growth factor replaces estrogen in the stimulation of female genital-tract growth and differentiation. Proc. Natl. Acad. Sci. U. S. A. 88: 21-25.
38. Nyberg, K. A., R. J. Michelson, C. W. Putnam, and T. A. Weinert. 2002. Toward maintaining the genome: DNA damage and replication checkpoints. Annu. Rev. Genet. 36: 617-656.
39. Pajalunga, D., and M. Crescenzi. 2004. Regulation of cyclin E protein levels through E2F-mediated inhibition of degradation. Cell Cycle 3: 1572-1578.
40. Pan, H., Y. Deng, and J. W. Pollard. 2006. Progesterone blocks estrogen-induced DNA synthesis through the inhibition of replication licensing. Proc. Natl. Acad. Sci. U. S. A. 103: 14021-14026.
41. Ramji, D. P., and P. Foka. 2002. CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem. J. 365: 561-575.
42. Reed, S. I. 2002. Cell cycling? Check your brakes. Nat. Cell Biol. 4: E199-E201.
43. Roos, W. A., and B. Kaina. 2006. DNA-damage induced cell death by apoptosis. Trends Mol. Med. 12: 440-450.
44. Sandelin, A., W. W. Wasserman, and B. Lenhard. 2004. ConSite: Web-based prediction of regulatory elements using cross-species comparison. Nucleic Acids Res. 32: W249-W252.
45. Schug, J., and G. C. Overton. 1997. TESS: transcription element search software on the WWW. Computational Biology and Informatics Laboratory, School of Medicine, University of Pennsylvania, Philadelphia, PA.
46. Sheaff, R. J., M. Groudine, M. Gordon, J. M. Roberts, and B. E. Clurman. 1997. Cyclin E-CDK2 is a regulator of p27Kip1. Genes Dev. 11: 1464-1478.
47. Sherr, C. J., and J. M. Roberts. 1999. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13: 1501-1512.
48. Sterneck, E., L. Tessarollo, and P. F. Johnson. 1997. An essential role for C/EBPbeta in female reproduction. Genes Dev. 11: 2153-2162.
49. Sterneck, E., S. Zhu, A. Ramirez, J. L. Jorcano, and R. C. Smart. 2005. Conditional ablation of C/EBP beta demonstrates its keratinocyte-specific requirement for cell survival and mouse skin tumorigenesis. Oncogene 25: 1272-1276.
50. Tong, W., and J. W. Pollard. 2002. Female sex steroid hormone regulation of cell proliferation in the endometrium, p. 94-109. In S. R. Glasser, J. D. Alpin, L. C. Giudice, and S. Tabibzadeh (ed.), Endometrium. Taylor & Francis, London, United Kingdom.
51. Tong, W., and J. W. Pollard. 1999. Progesterone inhibits estrogen-induced cyclin D1 and cdk4 nuclear translocation, cyclin E- and cyclin A-cdk2 kinase activation, and cell proliferation in uterine epithelial cells in mice. Mol. Cell. Biol. 19: 2251-2264.
52. Wang, Q., X. Li, L. Wang, Y.-H. Feng, R. Zeng, and G. Gorodeski. 2004. Antiapoptotic effects of estrogen in normal and cancer human cervical epithelial cells. Endocrinology 145: 5568-5579.
53. Webb, D., B. Moulton, and S. Khan. 1993. Estrogen induces expression of c-jun and jun-B protooncogenes in specific rat uterine cells. Endocrinology 133: 20-28.
54. Wedel, A., and H. A. Ziegler-Heitbrock. 1995. The C/EBP family of transcription factors. Immunobiology 193: 171-185.
55. Yamashita, S., A. Takayanagi, and N. Shimizu. 1996. Temporal and cell-type specific expression of c-fos and c-jun protooncogenes in the mouse uterus after estrogen stimulation. Endocrinology 137: 5468-5475.
56. Zhang, J.-W., Q.-Q. Tang, C. Vinson, and M. D. Lane. 2004. Dominant-negative C/EBP disrupts mitotic clonal expansion and differentiation of 3T3-L1 preadipocytes. Proc. Natl. Acad. Sci. U. S. A. 101: 43-47.
57. Zhou, B.-B. S., and S. J. Elledge. 2000. The DNA damage response: putting checkpoints in perspective. Nature 408: 433-439.
58. Zhu, S., K. Yoon, E. Sterneck, P. F. Johnson, and R. C. Smart. 2002. CCAAT/enhancer binding protein-beta is a mediator of keratinocyte survival and skin tumorigenesis involving oncogenic Ras signaling. Proc. Natl. Acad. Sci. U. S. A. 99: 207-212.